Novel Ti surface coated with PVA hydrogel and chitosan nanoparticles with antibacterial drug release: An experimental in vitro study
Metadatos
Mostrar el registro completo del ítemAutor
Carrazco Avila, Pablo Yael; Arias Moliz, María Teresa; Rosales Leal, Juan Ignacio; Baca García, María Pilar; Rodríguez Valverde, Miguel Ángel; Morales Hernández, María EncarnaciónEditorial
Wiley
Materia
biofilm chitosan dental implant
Fecha
2024-02-28Referencia bibliográfica
Carrazco A´ vila PY, Arias Moliz T, Rosales Leal JI, Baca P, Rodríguez Valverde MA´ , Morales Hernandez ME. Novel Ti surface coated with PVA hydrogel and chitosan nanoparticles with antibacterial drug release: An experimental in vitro study. Clin Implant Dent Relat Res. 2024; 26(2):427‐441. doi:10.1111/cid.13305
Patrocinador
Autonomous University of Sinaloa (México); Project PID2020.116082GB.I00 (MCIN/ AEI/10.13039/501100011033); Project C-CTS-305-UGR23 (University of Granada, Spain); Research group CTS-974 (Junta de Andalucía, Spain); Universidad de Granada / CBUAResumen
Objectives
The aims of this study were to design a novel titanium surface coated with a PVA hydrogel matrix and chitosan-based nanoparticles and to investigate the antibiotic release and its ability to inhibit microbial activity.
Methods
Two drug delivery systems were developed and mixed. Chitosan-based nanoparticles (NP) and a polyvinyl alcohol film (PVA). The size, ζ-potential, stability, adhesive properties, and encapsulation profile of NP, as well as the release kinetics of drug delivery systems and their antimicrobial ability of PVA and PVANP films, were studied on Ti surfaces. The systems were loaded with doxycycline, vancomycin, and doxepin hydrochloride.
Results
Nanoparticles presented a ζ-potential greater than 30 mV for 45 days and the efficiency drug encapsulation was 26.88% ± 1.51% for doxycycline, 16.09% ± 10.24% for vancomycin and 17.57% ± 11.08% for doxepin. In addition, PVA films were loaded with 125 μg/mL of doxycycline, 125 μg/mL of vancomycin, and 100 μg/mL of doxepin. PVANP-doxycycline achieved the antibacterial effect at 4 h while PVA-doxycycline maintained its effect at 24 h.